5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.22▼ | 1.22▼ | 1.22▼ | 1.27▼ | 1.36▼ |
MA10 | 1.22▼ | 1.22▼ | 1.23▼ | 1.27▼ | 1.46▼ |
MA20 | 1.22▼ | 1.23▼ | 1.26▼ | 1.43▼ | 1.33▼ |
MA50 | 1.22▼ | 1.29▼ | 1.28▼ | 1.44▼ | 1.98▼ |
MA100 | 1.26▼ | 1.28▼ | 1.37▼ | 1.33▼ | 3.23▼ |
MA200 | 1.29▼ | 1.40▼ | 1.51▼ | 1.83▼ | 5.05▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.002▲ | -0.005▼ | -0.025▼ | 0.041▲ |
RSI | 45.006▼ | 29.693▼ | 33.869▼ | 38.098▼ | 41.334▼ |
STOCH | 73.333 | 34.444 | 17.330▼ | 25.209 | 36.003 |
WILL %R | -60.000 | -71.429 | -86.667▼ | -92.708▼ | -76.503▼ |
CCI | -50.602 | -100.000 | -78.438 | -89.727 | -73.091 |
Monday, July 14, 2025 04:20 AM
The consolidation of the Philippine Dealing System Holdings Corp. boosted the earnings of the Philippine Stock Exchange Inc. by a quarter in the first half.
|
Thursday, July 10, 2025 07:19 AM
Shares of PDS Biotechnology Corp (NASDAQ:PDSB) increased 3.8% after the company revealed its clinical trial for metastatic colorectal cancer has met key benchmarks, allowing progression to Stage 2.
|
Thursday, July 03, 2025 05:00 PM
Find the latest institutional holdings data for PDS Biotechnology Corporation Common Stock (PDSB) including shareholders, ownership summaries, and holding activities at Nasdaq.com.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
14/07/25 | 1.225 | 1.24 | 1.205 | 1.215 | 378,538 |
11/07/25 | 1.28 | 1.30 | 1.225 | 1.24 | 449,537 |
10/07/25 | 1.37 | 1.40 | 1.27 | 1.30 | 885,024 |
09/07/25 | 1.27 | 1.38 | 1.27 | 1.32 | 400,283 |
08/07/25 | 1.23 | 1.31 | 1.23 | 1.27 | 400,668 |
07/07/25 | 1.32 | 1.3288 | 1.20 | 1.22 | 409,319 |
03/07/25 | 1.29 | 1.34 | 1.26 | 1.33 | 141,463 |
02/07/25 | 1.23 | 1.32 | 1.18 | 1.27 | 644,669 |
01/07/25 | 1.31 | 1.3399 | 1.205 | 1.22 | 648,669 |
30/06/25 | 1.41 | 1.43 | 1.32 | 1.33 | 544,310 |
|
|
||||
|
|
||||
|
|